BGI
ADMA icon

B Group Inc’s ADMA Biologics ADMA Stock Holding History

B Group Inc’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.9M Buy
3,207,542
+750,000
+31% +$11.8M 21.43% 1
2025
Q4 		$44.8M Buy
2,457,542
+45,000
+2% +$758K 33.1% 1
2025
Q3 		$35.4M Buy
2,412,542
+95,000
+4% +$1.63M 26.02% 1
2025
Q2 		$42.2M Hold
2,317,542
– – 32.48% 1
2025
Q1 		$46M Buy
2,317,542
+30,000
+1% +$519K 39.39% 1
2024
Q4 		$39.2M Buy
+2,287,542
New +$43M 23.98% 2

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

B Group Inc's ADMA Position: Q1 2026 in Review

B Group Inc increased its ADMA Biologics (ADMA) stake by 31% in Q1 2026, buying an estimated $11.8M and bringing the position to 3,207,542 shares worth $28.9M. The position accounts for 21.43% of the portfolio, ranked #1.

B Group Inc first reported a position in ADMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $46M in Q1 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • B Group Inc held 3,207,542 shares of ADMA Biologics worth $28.9M as of Q1 2026.
  • B Group Inc bought 750,000 ADMA Biologics shares in Q1 2026, an estimated $11.8M.
  • ADMA Biologics made up 21.43% of B Group Inc's portfolio in Q1 2026, its #1 holding.
  • B Group Inc first reported a position in ADMA Biologics in Q4 2024 and has held it in 6 quarters since.
  • B Group Inc's ADMA Biologics position peaked at $46M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.